Abstract:The isolated copper(II) complex [CuL(-phen)]·HO () [HL = -HO-CHC(H)=N-CH-SH-, -phen = 1,10-phenanthroline] was structurally characterized using single-crystal X-ray crystallography. in CHCN at liquid nitrogen temperature displayed a characteristic monomeric X-band electron paramagnetic resonance spectrum having a tetragonal character with = 2.1479 and = 2.0691 and ≈ 18.0 mT and ≤ 3.9 mT, respectively. showed a strong binding affinity toward calf thymus DNA as reflected from its intrinsic binding constant ( = 7.88 × 10 M), and its competitive displacement of ethidium bromide suggested an intercalative DNA-binding mode ( = 1.32 × 10 M). This was confirmed from the viscosity study that showed an increase in the viscosity of DNA with an increasing concentration of . Complex is highly efficient in promoting oxidative and hydrolytic DNA cleavage ( = 1.987 h). showed a strong binding affinity with the carrier protein human serum albumin (HSA) ( = 5.22 × 10 M). A high bimolecular quenching constant = 2.29 × 10 Ms indicated a static quenching mechanism involved in the fluorescence quenching of HSA by . Fluorescence resonance energy transfer theory suggested that the distance ( = 3.52 nm) between and HSA is very close. Molecular docking studies suggested that primarily binds to HSA in subdomain IIA. A protein-ligand interaction profiler was used to visualize hydrophobic, hydrogen bonds, and π-cation interactions between HSA and . A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay using HeLa and MDA-MB-231 cells showed a significant in vitro anticancer activity of (IC 2.63 and 2.68 μM, respectively). Nuclear staining assays suggested apoptotic cell death in HeLa cells treated with . The effect of on the cytoskeletal actin filaments visualized using phalloidin staining showed extensive destruction of actin filaments. Flow cytometric analysis indicated that inhibits the growth of HeLa cells through cell cycle arrest in the S phase. Western blot analysis showed upregulation in the expression of apoptotic marker proteins caspase 3, p53, and Bax. These results collectively indicate that induces apoptosis by promoting DNA damage and has a high potential to act as an anticancer agent.

Experimental and molecular modelling demonstration of effective DNA and protein binding as well as anticancer potential of two mononuclear Cu(II) and Co(II) complexes with isothiocyanate and azide as anionic residues

DNA incision evaluation, binding investigation and biocidal screening of Cu(II), Ni(II) and Co(II) complexes with isoxazole Schiff bases

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

Two novel homo/hetero polynuclear complexes for DNA binding, molecular docking and anti-cancer activity

Synthesis, Characterization, Investigation of DNA Interactions and Biological Evaluation of Co(II), Ni(II), Cu(II) and Zn(II) Complexes with Newly Synthesized 2-methoxy 5-trifluoromethyl benzenamine Schiff Base

Investigation of protein/DNA binding, and in vitro cytotoxicity of novel Cu (II) and Zn (II)-dipyrazinyl pyridine complexes

Mononuclear Copper(II) Complexes with Polypyridyl Ligands: Synthesis, Characterization, DNA Interactions/Cleavages and in vitro Cytotoxicity towards Human Cancer Cells

Mixed Ligand Mononuclear Copper(II) Complex as a Promising Anticancer Agent: Interaction Studies with DNA/HSA, Molecular Docking, and In Vitro Cytotoxicity Studies.

Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1H-imidazol-2-yl)pyridine and amino acids

Synthesis, characterization, biological potency, and molecular docking of Co2+, Ni2+ and Cu2+ complexes of a benzoyl isothiocyanate based ligand

DNA Binding and in Vitro Anticarcinogenic Activity of a Series of Newfashioned Cu(II)-complexes Based on Tricationic Metalloporphyrin Salicyloylhydrazone Ligands.

A series of DNA targeted Cu (II) complexes containing 1,8-naphthalimide ligands: Synthesis, characterization and in vitro anticancer activity

Synthesis and Crystal Structure of New Dicopper(Ii) Complexes Having Asymmetric N,N '-Bis(substituted)oxamides with Dna/Protein Binding Ability: in Vitro Anticancer Activity and Molecular Docking Studies

1‐Benzyl‐1H‐indazol‐3‐ol Copper(II) Derivatives as Anticancer Agents: In‐vitro Interaction with DNA/BSA, DFT, Molecular Docking and Cytotoxicity on MCF7 Cells

Synthesis, Characterization, DNA/HSA Interactions, and Anticancer Activity of Two Novel Copper(II) Complexes with 4-Chloro-3-Nitrobenzoic Acid Ligand

Molecular docking and biological activities of Ni(II), Cu(II) and Co(II) complexes with a new potentially hexadentate polyamine ligand; X-ray crystal structure of the Cu(II) complex

Synthesis, Crystal Structure, Biomolecular Interactions and Anticancer Properties of Ni(II), Cu(II) and Zn(II) Complexes Bearing S-allyldithiocarbazate

Crystal structure, in vitro cytotoxicity, DNA binding and DFT calculations of new copper (II) complexes with coumarin-amide ligand

Synthesis, characterization of Schiff base metal complexes with 1, 3 propanediamine as secondary chelates and their DNA binding, DNA cleavage, cytotoxicity, antioxidant and activities

Synthesis and Crystal Structure of a New Copper(ii) Complex with N,N′-(4,4′-bithiazole-2,2′-diyl)diacetimidamide As Ligand: Molecular Docking, DNA-binding and Cytotoxicity Activity Studies

Biomolecular Interaction, Anti-Cancer and Anti-Angiogenic Properties of Cobalt(III) Schiff Base Complexes